immune thrombocytopenia
Conditions
Interventions
Divided by disease course into New diagnosed ITP, chronic ITP, persistent ITP:NA
Sponsors
The affiliated people's hospital of Ningbo University
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. According to the "Chinese Guidelines for Diagnosis and Treatment of Adult Primary Immune Thrombocytopenia (2020 Edition)", patients diagnosed with ITP who are ineffective in splenectomy or have not undergone splenectomy but are ineffective in treating = 2 types of ITP, or who relapse after ITP treatment. 2. Platelet count<30 × 10^9/L before using romiplostim; 3. ECOG score = 2 points; 4. Complete clinical data and voluntary signing of informed consent form.
Exclusion criteria
Exclusion criteria: 1. Merge other blood system diseases; 2. Merge important organ dysfunction; 3. Merge uncontrollable infections, such as active tuberculosis, etc; 4. Recent occurrence of any arterial or venous thrombosis, or clinical symptoms and medical history indicating thrombophilia; 5. Pregnant or lactating women; 6. Allergic to romiplostim.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| platelet count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver function; | — |
Countries
China
Contacts
Public ContactShen Minli
The affiliated people's hospital of Ningbo University
Outcome results
None listed